Your browser doesn't support javascript.
loading
Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.
De Souza, Andre; Tavora, Fabio A; Mahalingam, Devalingam; Munster, Pamela N; Safran, Howard P; El-Deiry, Wafik S; Carneiro, Benedito A.
Affiliation
  • De Souza A; Division of Hematology/Oncology, Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI, United States.
  • Tavora FA; Argos Laboratory, Fortaleza, Brazil.
  • Mahalingam D; Division of Hematology/Oncology, Northwestern University, Chicago, IL, United States.
  • Munster PN; Department of Medicine (Hematology/Oncology), Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States.
  • Safran HP; Division of Hematology/Oncology, Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI, United States.
  • El-Deiry WS; Division of Hematology/Oncology, Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI, United States.
  • Carneiro BA; Department of Pathology and Laboratory Medicine, Alpert Medical School of Brown University, Providence, RI, United States.
Front Immunol ; 11: 595289, 2020.
Article in En | MEDLINE | ID: mdl-33193448
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycogen Synthase Kinase 3 / Immune System Phenomena Language: En Journal: Front Immunol Year: 2020 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycogen Synthase Kinase 3 / Immune System Phenomena Language: En Journal: Front Immunol Year: 2020 Type: Article Affiliation country: United States